Cite
HARVARD Citation
Lathouwers, E. et al. (2021). Week 96 resistance analyses of the once‐daily, single‐tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in adults living with HIV‐1 from the phase 3 randomized AMBER and EMERALD trials. Journal of medical virology. 93 (6), pp. 3985-3990. [Online].